Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.
about
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.Optimizing treatments for anxiety by age and geneticsPharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersFluoxetine Facilitates Fear Extinction Through Amygdala EndocannabinoidsMechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disordersAn Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical TrialsCan fear extinction be enhanced? A review of pharmacological and behavioral findings.Chronic antidepressant treatment impairs the acquisition of fear extinction.Prefrontal single-unit firing associated with deficient extinction in mice.Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinctionEasy to remember, difficult to forget: the development of fear regulationSerotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memoryExtinction retention and fear renewal in a lifetime obsessive-compulsive disorder sample.Risk for anxiety and implications for treatment: developmental, environmental, and genetic factors governing fear regulation.On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.Fear erasure in mice requires synergy between antidepressant drugs and extinction training.Pattern of distribution of serotonergic fibers to the amygdala and extended amygdala in the rat.Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear.Mineralocorticoid receptors in the ventral hippocampus are involved in extinction memory in rats.
P2860
Q26767636-BD789B59-06F4-4068-9536-7370CD0B5564Q26823694-59024881-11E0-46DF-AE74-C6FE186FE413Q27006437-63A768F3-50F4-444D-87ED-FADEABB436A8Q27310769-8CEE6D40-75BA-41C1-A135-1BA0451C2F99Q28396555-A4D87B23-C685-4A28-8237-D2969FFB50FCQ30375098-2F36787E-FEDF-4A29-9CAB-A5904A4587CDQ30410131-5FCB0C01-AE8D-4DDE-8A1C-24F89B6A1B14Q30437449-26774FF6-D78C-4CBF-A707-5EA6D5BE6835Q33594739-60B7FF54-A76E-4AC6-9E94-7D5753793BDDQ33931858-A9B8F21A-7100-47AF-A3EF-56220F210AE7Q35835627-6248DB14-9923-4EE4-9BD8-3A003F974475Q35887089-FB6C2941-25F7-4256-99AE-169905FB7B1FQ36132946-D42A186D-EC54-42A7-A2D7-E2192C321463Q37350962-5019C9B2-8993-48EF-8F58-56083FBDC3EBQ38852116-AFCCB836-43A7-4064-A655-4F65F9EFDE7EQ41967620-F4BE661B-B8CD-440C-9A6D-AA35FCB8A657Q42493544-3CDFBCAD-A3B5-4AAD-8F0C-FF78CA45C8B8Q47350191-367399AF-C14E-4A07-A24A-06F90DFC2D33Q50574306-EFBE3D4C-53BB-4E8B-8C2C-5A3B6946304C
P2860
Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@en
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@nl
type
label
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@en
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@nl
prefLabel
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@en
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@nl
P2093
P2860
P1433
P1476
Chronic treatment with fluoxet ...... uditory-cued conditioned fear.
@en
P2093
Guillaume Spennato
Jean-Luc Moreau
Olivier Deschaux
René Garcia
P2860
P2888
P304
P356
10.1007/S00213-010-2134-Y
P577
2010-12-22T00:00:00Z
P5875
P6179
1039064613